FORWARD FEATURES CALENDAR

Managers

Private capital fund managers raise fee rates in 2017, says Preqin

The 2017 Preqin Private Capital Fund Terms Advisor finds that several private capital fund types are raising their average management fees among funds of more recent vintages. Unlisted infrastructure funds have seen mean management fees rise marginally from lows of 1.38 per cent for 2014 vintage funds to 1.48 per

Farah Ballands, Estera

Estera gains Headstart in Luxembourg

Global fiduciary and administration services provider Estera has acquired Headstart, a specialist corporate and trust services business in Luxembourg. The transaction paves the way for Estera’s expansion into Luxembourg, one of world’s most important jurisdictions for funds and corporate services, while also broadening the company’s offering in corporate, fund and

Matt Mulry, Dillon Eustace

Building investment fund structures – from start-up to stardom

By Matt Mulry, Dillon Eustace – Whether you’re looking to launch a private equity fund focused on venture capital, real estate, infrastructure, technology, energy, health care or art or a hedge fund focused on global macro, long/short equity, special situations, fixed-income or commodities the Cayman Islands is a great place

WFW advises IREP on acquisition of Cluttons APAC business

International law firm Watson Farley & Williams (WFW) has advised Dubai-based International Real Estate Partnership Holdings (IREP) on the purchase from administrators Mark Fry and Gary Shankland of Begbies Traynor (London) of the Asia-Pacific business of real estate consultancy and services company Cluttons. This follows the acquisition by specialist turn-around

Leesa Sleep raises USD23m

Leesa Sleep, a direct-to-consumer online luxury mattress retailer, has raised GBP17.6m in a Series B funding round led by One Better Ventures, an investment company led by John Replogle. Replogle will join Leesa as Chairman of the Board alongside Peter Graham who was Chairman of Seventh Generation until its recent sale

Allegro Ophthalmics secures USD10.7m in private financing

Allegro Ophthalmics, a biotechnology company focused on the development of novel therapies to treat vitreoretinal diseases has completed a private round of equity financing for USD10.7 million. With this infusion of capital, the company is strongly positioned to reach future corporate milestones. Allegro is . The company’s lead drug candidate,

BlackFin completes first closing of VC fund in excess of EUR100m

BlackFin Capital Partners completed a first closing in excess of EUR100 million for its BlackFin Tech Fund 1 from European institutional investors such as Bpifrance, Vaudoise Assurances Group, Groupama Group, Sogecap (Société Générale Insurance), Natixis Assurances, Swiss Life as well as several banks and family-offices. This closing paves the way

Events

12 November, 2026 – 5:00 pm

Directory Listings